NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-071-2012-0-US-01 BISPECIFIC ANTIBODIES TO TREAT HIV-1 INFECTION US 61/638,437 Abandoned
NEI E-036-2012-0-US-01 Methods of Producing And Using Regulatory B Cells US 61/637,915 Abandoned
NIA E-158-2012-1-US-01 Use Of Erythropoietin And Derivatives For Treating Hypertension US 61/638,328 Abandoned
NCI E-039-2003-0-US-04 Individualized Therapy Using Interdependent Protein Signal Network US CON 13/455,111 8835360 Expired PDF
NCATS E-094-2011-0-PCT-02 Inhibitors Of Human Apurinic/Apyrimidinic Endonuclease 1 PCT PCT PCT/US12/34755 Abandoned
NCI E-132-2010-0-US-03 Methods Of Diagnosing And Prognosing Colonic Polyps US National Stage 13/504,154 Abandoned
NCI E-144-2011-0-PCT-02 Transient Hypoxia Inducers And Their Use PCT PCT PCT/US2012/034534 Expired
NIA E-158-2012-0-US-01 Use of Erythropoietin And Derivatives For Treating Hypertension US 61/636,547 Abandoned
NCI E-130-2011-0-CN-13 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof CN DIV 201610290837.3 Issued
NCI E-130-2011-0-HK-11 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof HK National Stage 16108042.3 Issued
NCI E-130-2011-0-EP-07 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof EP DIV 15188264.4 Issued
NCI E-130-2011-0-EP-14 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof EP DIV 16166924.7 Issued
NCI E-130-2011-0-IT-20 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof IT EP 16166924.7 Issued
NCI E-130-2011-0-FR-18 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof FR EP 16166924.7 Issued
NCI E-130-2011-0-DE-16 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof DE EP 16166924.7 Issued
NCI E-130-2011-0-GB-19 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof GB EP 16166924.7 Issued
NCI E-130-2011-0-ES-17 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof ES EP 16166924.7 Issued
NIDCR E-142-2011-0-EP-04 AAV Mediated Exendin-4 Gene Transfer to Salivary Glands to Protect Subjects From Diabetes or Obesity EP National Stage 12773975.3 Issued
NIAID E-283-2009-1-US-06 Compounds That Treat Malaria And Prevent Malaria Transmission US National Stage 13/392,668 9375424 Issued PDF
NCI E-130-2011-0-CN-03 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof CN National Stage 201280029201.3 Issued
NCI E-130-2011-0-GB-10 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof GB EP 12717009.0 Issued
NCI E-130-2011-0-FR-09 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof FR EP 12717009.0 Issued
NCI E-130-2011-0-DE-08 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof DE EP 12717009.0 Issued
NCI E-130-2011-0-EP-04 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof EP National Stage 12717009.0 Issued
NIDCR E-142-2011-0-PCT-02 AAV Mediated Exendin-4 Gene Transfer to Salivary Glands to Protect Subject From Diabetes or Obesity PCT PCT PCT/US12/34268 Expired
NCI E-130-2011-0-PCT-02 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof PCT PCT PCT/US2012/034186 Expired
NIDCR E-142-2011-0-CA-03 AAV Mediated Exendin-4 Gene Transfer to Salivary Glands to Protect Subject From Diabetes or Obesity CA National Stage 2833623 Abandoned
NCI E-268-2012-0-EP-04 Discovery Of Niclosamide As A Lead For Inlnbition Of S100A4 Transcription And Metastasis EP National Stage 12717643.6 Issued
NCI E-268-2012-0-PCT-02 Discovery Of Niclosamide As A Lead For Inlnbition Of S100A4 Transcription And Metastasis PCT PCT PCT/EP2012/057049 Expired
NHLBI E-143-2012-0-US-01 Phase Sensitive Motion Correction And Tl Mapping For Cardiovascular Magnetic Resonance Imaging US 61/625,254 Abandoned
NIAID E-007-2010-1-US-02 NUCLEIC ACID SEQUENCES ENCODING EXPANDABLE HIV MOSAIC PROTEINS US National Stage 13/502,206 Abandoned
NIAAA E-070-2012-0-US-01 Derivatives Of Docosahexaenoylamide and Uses Thereof US 61/624,741 Abandoned
NINDS E-050-2011-0-PCT-02 Isoindoline Compounds For The Treatment Of Spinal Muscular Atrophy And Other Uses PCT PCT PCT/US2012/033589 Expired
NIDCR E-087-2011-0-PCT-02 AAV Mediated CTLA-4 Gene Transfer to Treat Sjogren's Syndrome PCT PCT PCT/US12/33556 Expired
NCI E-273-2002-0-US-04 NITROXYL PROGENITORS IN THE TREATMENT OF HEART FAILURE US CON 13/446,700 Abandoned
NIDCR E-087-2011-0-EP-03 AAV Mediated CTLA-4 Gene Transfer to Treat Sjogren's Syndrome EP National Stage 12771864.1 Abandoned
NCI E-142-2012-0-US-01 Fas Agonists And Antagonists As T-Cell Differentiation Modulators US 61/623,733 Abandoned
NIAID E-135-2010-0-US-01 Genetically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production US 61/624,010 Abandoned
NCI E-181-2009-4-AU-02 Peptide and Peptide Mimetic Binding Antagonists of Polo-like Kinase1 Polo Box Domain and Methods of Use AU National Stage 2012242784 Abandoned
NINDS E-014-2006-2-US-13 In-vitro Assay To Screen For Enhancement Of Mutated Alpha-galactosidase A (GLA) By Small Molecules Chaperones For Fabry Disease US CON 13/445,338 9000011 Issued PDF
NCI E-158-2009-0-US-06 Granulysin In Immunotherapy US National Stage 13/501,726 8815229 Abandoned PDF
NCI E-141-2008-0-NZ-11 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof NZ DIV 599338 Issued
NCI E-181-2009-4-PCT-01 Peptide Mimetic Ligands of Polo-like Kinase1 Polo Box Domain and Method of Use PCT PCT COMB PCT/US2012/033259 Expired
NCI E-181-2009-4-EP-04 Peptide Mimetic Binding Ligands of Polo-like Kinase1 Polo Box Domain and Methods of Use EP National Stage 12722945.8 Abandoned
CC E-170-2012-0-US-01 LARGE VOLUME, CONFORMAL HYPERTHERMIA WITH MAGNETIC RESONANCE-GUIDED HIGH INTENSITY FOCUSED ULTRASOUND US 61/623,355 Abandoned
NCI E-181-2009-4-CA-03 Peptide Mimetic Ligands of Polo-like Kinase1 Polo Box Domain and Method of Use CA National Stage 2832073 Abandoned
NIAID E-145-2011-0-BE-19 Plasmodial Surface Anion Channel Inhibitors For The Treatment Of Prevention Of Malaria BE EP 12770599.4 Issued
NIAID E-145-2011-0-EP-05 Plasmodial Surface Anion Channel Inhibitors For The Treatment Of Prevention Of Malaria EP National Stage 12770599.4 Issued
NIAID E-145-2011-0-GB-20 Plasmodial Surface Anion Channel Inhibitors For The Treatment Of Prevention Of Malaria GB EP 12770599.4 Issued
NIAID E-145-2011-0-IN-07 PLASMODIAL SURFACE ANION CHANNEL INHIBITORS FOR THE TREATMENT OR PREVENTION OF MALARIA IN National Stage 8175/CHENP/2013 Issued